Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

CONTOURMED — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

CONTOURMED

via THEODOSIOU CONSULTANTS

2nd Quarter (Apr 1 - June 30) · 2011Posted Jul 18, 2011Filing document ↗LDA record ↗

Income$35Kfee reported

Client

Name: CONTOURMED
Description: Medical Devices
Location: Arkansas · United States of America

Registrant

Firm: THEODOSIOU CONSULTANTS
Description: Lobbying/consultant
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
S.1217 H.R. 2233 "The Breast Cancer Patient Equity Act of 2011"
LobbyistsPHILLIP THEODOSIOU
Covered position (PHILLIP THEODOSIOU): Principal
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.